Journal List > J Korean Med Sci > v.39(32) > 1516088072

Alnaimat, Al-Halaseh, and AlSamhori: Evolution of Research Reporting Standards: Adapting to the Influence of Artificial Intelligence, Statistics Software, and Writing Tools

Abstract

Reporting standards are essential to health research as they improve accuracy and transparency. Over time, significant changes have occurred to the requirements for reporting research to ensure comprehensive and transparent reporting across a range of study domains and foster methodological rigor. The establishment of the Declaration of Helsinki, Consolidated Standards of Reporting Trials (CONSORT), Strengthening the Reporting of Observational Studies in Epidemiology (STROBE), and Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) are just a few of the historic initiatives that have increased research transparency. Through enhanced discoverability, statistical analysis facilitation, article quality enhancement, and language barrier reduction, artificial intelligence (AI)—in particular, large language models like ChatGPT—has transformed academic writing. However, problems with errors that could occur and the need for transparency while utilizing AI tools still exist. Modifying reporting rules to include AI-driven writing tools such as ChatGPT is ethically and practically challenging. In academic writing, precautions for truth, privacy, and responsibility are necessary due to concerns about biases, openness, data limits, and potential legal ramifications. The CONSORT-AI and Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT)-AI Steering Group expands the CONSORT guidelines for AI clinical trials—new checklists like METRICS and CLEAR help to promote transparency in AI studies. Responsible usage of technology in research and writing software adoption requires interdisciplinary collaboration and ethical assessment. This study explores the impact of AI technologies, specifically ChatGPT, on past reporting standards and the need for revised guidelines for open, reproducible, and robust scientific publications.

INTRODUCTION

There is a growing emphasis on identifying and preventing unethical behavior and detrimental research practices in order to enhance the integrity and openness of scientific studies.1 By enhancing the precision, comprehensiveness, and transparency of research reporting, reporting standards play a critical role in the field of health research.12
Furthermore, the significance of reporting standards goes beyond supporting the meticulous evaluation of study methodology and outcome validity, as they also improve the caliber of evidence synthesis for application in the real world of healthcare. Inadequate reporting hinders the reproducibility of research findings, wastes time and resources, and distorts the available data.3 The comprehensiveness of trial reporting in medical publications is improved by reporting guidelines, such as Consolidated Standards of Reporting Trials (CONSORT), the gold standard for randomized controlled trials (RCTs).3 Although there has been a recent drive for more research transparency, there are still large gaps between stated ideas and actual actions. It has been observed that these gaps can be caused by several variables, including traditions, expectations, and practical considerations when publishing scientific data.1
A reporting guideline’s central checklist outlines the crucial data that must be included in a published article.1 These checklists are based on practices and represent the industry’s duty to ensure the quality and safety of processes and products, especially in high-risk circumstances.4 The World Health Organization surgical safety checklist exemplifies how considerable reductions in post-operative complications and fatality rates have been attained.56
This work contributes to a better understanding of past adherence to reporting standards and the influence of artificial intelligence (AI) technological advances on these processes. This review emphasizes the importance of revised guidelines for ensuring open, reproducible, and robustly conducted current scientific publications. It achieves this by looking into the influence of AI technologies, specifically ChatGPT, on data collection and processing, as well as methodologies for research.

Aims of the paper

  • 1. To provide a historical comprehensive overview of the importance and evolution of research reporting standards.

  • 2. To explore the impact of AI on data collection, analysis, and adherence, as well as what recent changes have been made in response to AI-driven research.

  • 3. To assess the role of commonly used statistical software in affecting reporting standards and guidelines.

  • 4. To provide an overview of the implications of writing software on research reporting and publication ethics.

  • 5. To identify the challenges and considerations of adapting research reporting standards in an ethical manner to ensure reproducibility and replicability.

  • 6. To discuss future directions and provide recommendations for improving research reporting standards.

LITERATURE SEARCH

A thorough review of the literature published in PubMed and Scopus electronic databases was performed to extract published manuscripts until March 30th, 2024, following the recommendations published by Gasparyan et al.7 Only English-language sources were considered, using the search terms: “Reporting Standards,” “Artificial Intelligence,” “Statistics Software,” and “Large Language Models.” The inclusion criteria for selecting articles were articles published up to March 30, 2024, indexed in PubMed and Scopus databases, written in English, and relevant to health research and the impact of AI in this field. We excluded articles that did not fulfill those inclusion criteria. Articles were initially screened based on their title and abstract, and full texts were reviewed to ensure relevance. The search results can be found throughout this review.

EVOLUTION OF RESEARCH REPORTING STANDARDS

The growth of reporting standards in medical research has been characterized by a progressive understanding of the value of well-designed trials and open reporting.8 Throughout the twentieth century, there were concerns regarding the quality and knowledge of research methodologies.9 However, it wasn’t until the late twentieth century and early twenty-first century that a substantial focus was placed on the inadequate reporting in published journal papers.89

Early criticisms (20th century)

Research methods developed in the early 20th century reveal weaknesses in statistical analysis and clinical data. Researchers like Halbert Dunn highlight that medical research has been criticized for lacking methodological rigor and statistical logic.10

Growing concerns (late 20th century)

A lack of statistical planning and evaluation in published articles raised concerns about inadequate technique. Studies examining research report quality found significant percentages of methodological errors.11

Introduction of reporting guidelines

To address these concerns, initiatives were taken to enhance reporting standards. In the 1990s, preliminary recommendations were made about the contents of research publications. Eventually, specific reporting guidelines were created, including RCTs, which are made to accommodate various types of investigations.1213

The CONSORT statement

The first RCT reporting flow diagram and checklist were released in 1996. Their main objectives were to ensure the transparency and completeness of trial reports and correct shortcomings in RCT reporting.14
The influence of CONSORT has greatly affected the evolution of reporting requirements for other study types and RCTs. Also, its methodology, which focused more on reporting than study conduct, was used as a model for other reporting guidelines. Accessible evidence was drawn upon where necessary, and adjustments were made over time to accommodate new evidence and viewpoints.8

The Enhancing the Quality and Transparency Of health Research (EQUATOR) Network

This was founded in 2006 to address the issue of inadequate reporting systematically and globally. Its goal was to unite individuals engaged in research reporting to advance the creation, distribution, and adoption of reporting standards.815
The Global Impact of The EQUATOR Network has enabled the promotion of reporting standards, the provision of tools and training, and the expansion of research into research methodologies. Even though it has improved reporting criteria, there are still issues in ensuring these guidelines are widely adopted and followed.1115

HISTORICAL PERSPECTIVE ON RESEARCH REPORTING STANDARDS

Over the course of a century, there have been various comments of concern over the quality of medical research and for almost as long, there has been much debate about the issues surrounding the quality of research reports.8 The Declaration of Helsinki, first published in 1964, is regarded as a foundational work in human research ethics. It was among the first to expressly address moral issues in human subjects’ medical research.16
Research reporting standards have been continuously developed in the field of research.81718 Moments that demonstrate attempts to increase the transparency and rigor of scientific research indicate the development of research reporting standards.819 Guidelines were established due to early detection of reporting inadequacies.18 These benchmarks include realizing the impact of incomplete reporting on reproducibility, working together to find gaps in reporting procedures, and continuously improving standards to stay updated with changing research techniques.20
Developing reporting rules for particular study designs, determining core outcome sets to improve comparability, and including patient viewpoints in health research reporting are examples of critical moments.212223 These benchmarks highlight the iterative process of improvement propelled by the widespread recognition of the significance of thorough and open reporting in the health sciences.2425 Important organizations have greatly helped the establishment and promotion of standards for research reporting.26
RCTs are fundamental to clinical research to treatments to assess treatments’ safety and effectiveness. RCTs, regarded as the gold standard, objectively assess research outcomes by randomly assigning patients to different therapy.27 One outstanding example of how to improve the standard of clinical trial reporting is CONSORT.3 The CONSORT statement was first provided in 1996 and revised in 2010 to guarantee that RCTs are reported without ambiguity. Consensus on Study Design, Methodology, and Performance CONSORT provides internationally accepted principles for reporting individually randomized parallel comparisons between two groups.28
To assist researchers in publishing cross-sectional, cohort, and case-control studies by fulfilling specific requirements for each type of study, Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) was established in 2004. The criteria for observational studies have been raised as a result.29 By making sure that crucial information on the methodology, conclusions, and discussion is accurately reported in scientific publications, STROBE and CONSORT contribute to the improvement of the thoroughness and clarity of study reporting.30
The Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) declaration acts as a guide for both, and PRISMA has had a significant influence on the reporting of both systematic reviews and meta-analyses31; PRISMA provides authors with a list of 27 critical criteria that they can utilize to help them write thorough and trustworthy summaries of study findings. This invites readers to offer a critical assessment of the work. The collaborative efforts of standards-setting bodies and reporting laws improve the caliber and openness of published medical research.32
These standards-setting bodies have established authoritative sources for researchers seeking guidance on transparent and comprehensive reporting across diverse research domains through international cooperation and interdisciplinary engagement.33
In the contemporary research landscape, myriad reporting guidelines cater to the specific needs of various research methodologies and study designs.34 Researchers can access a wealth of structured frameworks to transparently report methods, results, and interpretations.35 The Transparent Reporting of Evaluations with Nonrandomized Designs (TREND) for nonrandomized studies.36 and the diversity and specificity of available reporting guidelines are illustrated by the comprehensive collection by the EQUATOR Network.2
Researchers are empowered with tools that align with the intricacies of their research paradigms.37 The existence of these guidelines not only facilitates clear communication of scientific findings but also fosters a culture of methodological rigor and reproducibility.81937

THE EMERGENCE OF AI

AI can be defined in many ways. Some consider it the technology developed to let computers and other machinery operate intelligently.38 In contrast, AI can be viewed as a machine that replaces human labor and produces faster and more effective results for humankind.39 For others, it is perceived as “a system” that can accurately understand outside information, learn from it, and apply that learning to accomplish objectives and activities via adaptable modification.4041
The impact of AI on health research can be highlighted in the following points:
  • 1. AI is a powerful referencing tool that tracks recent literature, finds relevant papers, maps knowledge areas, and generates syntheses on specific research questions. Platforms like Google Scholar, Iris.ai, and Elicit.org enable researchers to navigate literature efficiently, saving time and effort in literature review processes.42

  • 2. AI can improve research designs by assisting researchers in selecting appropriate research methods, validating results, and designing research instruments.42

  • 3. AI can help researchers improve survey research by assisting in various aspects, including survey design, sampling, data cleaning, analysis, and reporting, thus improving the quality and efficiency of the research process.43

The increasing usage of writing software and statistics research has become essential to modern empirical investigations in healthcare sciences.44 Statistical software development has completely changed how researchers and scientists analyze data.44 Because modern software tools are so accurate and efficient, performing extensive statistical analyses by hand is now outmoded and prone to errors.45 Moreover, a clear benefit comes from simplified data interpretation using visual aids like graphs and charts to improve understanding and results dissemination,46 accepting many kinds of data, such as category and numeric values. By incorporating a variety of statistical tests into their frameworks, these tools streamline the computation of results.46 Research has revealed which statistical software is most used and preferred in studies. Because of its extensive capability and easy-to-use interface, the Statistical Package for Social Sciences (SPSS) is often used for epidemiological studies.47 On the other hand, because of its sophisticated commands, Statistical Analysis Systems (SAS) may be difficult for inexperienced users, although offering more flexibility and sophisticated graphical features.48 Another well-known tool is Stata, which provides a strong programming language for data analysis that supports both conventional and unconventional approaches.49

RESEARCH REPORTING STANDARDS IN THE AGE OF AI

AI has rapidly evolved into a widely recognized buzzword, joining discussions across diverse industries and academic disciplines. The utilization of AI machines, exemplified by technologies like ChatGPT, has attracted significant attention in recent years.
Academic writing notably benefits from adopting large language models (LLMs), which are models that produce languages that appear to have been developed by people using computational AI approaches.5051 By assisting writers with writing, grammar, and language usage, they can raise the quality of manuscripts, which results in well-written articles that follow precise guidelines for coherence and clarity and are logically organized.52 LLMs also play a part in breaking down language barriers by offering non-English-speaking writers with a free tool for language editing services.53 and LLMs helps scholars understand challenging topics, review long materials, and produce well-organized summaries.54 Accordingly, literature synthesis is accelerated, enabling a thorough comprehension of complex concepts.
Additionally, LLMs are crucial in streamlining the reporting of research findings by facilitating statistical analysis and guaranteeing accuracy and clarity in presenting results, and they help writers adhere to stringent reporting requirements.5255 Additionally, after a publication, LLMs improve the discoverability of scientific material.52 They also assist writers with the literature evaluation phase,56 and because they can manage enormous volumes of data, they are suitable for applications that require processing huge datasets. 4
Publishers have responded to the launch of LLMS; for example, Science, a prestigious publication, like many others, updated its editorial guidelines to expressly forbid ChatGPT content and make it clear that the software cannot be credited as an author. Editors have raised concerns about researchers relying on ChatGPT and other AI programs while preparing manuscripts.57 They point out likely errors and the risk that literature reviews and findings summaries won’t provide enough context or examination.58 Even with all the hype surrounding ChatGPT, they emphasize how important it is to maintain high standards in academic writing.596061
Despite being educated on enormous datasets and based on transformer architecture, LLMs still have issues, such as producing false information. Multiple research studies conducted in 2023 showed that LLMs could occasionally provide a more accurate rheumatological diagnosis than rheumatologists.62 However, the study also emphasized the dangers of false positives and misinterpreted data.60616263
The Committee on Publication Ethics (COPE) joined the Journal of the American Medical Association (JAMA) and the World Association of Medical Editors (WAME) organizations to conclude that authors utilizing AI tools in manuscript writing, image/graphic creation, or data collection/analysis must transparently disclose the AI tool’s usage and specify the tool in the Materials and Methods section. Authors bear full responsibility for their manuscripts, including AI-generated content, and are accountable for publication ethics violations.6465

THE ROLE OF STATISTICS SOFTWARE IN RESEARCH REPORTING

When designing a clinical trial or laboratory experiment, statistics play a crucial role in determining the design and sample size that will maximize the likelihood of finding effects of clinical or scientific interest. Additionally, statistics are utilized in data analysis to validate conclusions for a larger population.66 Many statistical software, such as SPSS Statistics, SAS, and Microsoft Excel, are currently being used. In an era marked by a surge in healthcare data, statistical analysis is a key player in medical research, offering a robust framework for unraveling complex datasets and extracting meaningful insights.67
Statistics are necessary for published findings to be considered as reputable and for medical research to offer insightful conclusions.68 Researcher examination of data educated decision-making, and creation of visually appealing reports are all made possible by statistical software.69 Statistics allows researchers to see beyond raw data to identify patterns, relationships, and trends, which helps them come to conclusions backed by evidence.70
Using these techniques, real impacts are separated from chance, guaranteeing that the published results are accurate and not just insignificant.71 Statistical software makes group comparisons easier and provides information on risk variables, treatment effectiveness, and other relevant comparisons.72
These software tools are more than just computational tools; they are facilitators that let researchers examine, evaluate, and present data in previously unheard-of ways.7374 The smooth incorporation of these technologies into the research workflow streamlines processes, promoting more accurate and efficient analyses.75
Research outputs’ quality and transparency are supported by the cooperation of statistical software and reporting guidelines.76 By automating sophisticated computations and testing, these technologies reduce the possibility of human error—a critical concern when working with big datasets.77
Statistical software generates standardized output that ensures reporting uniformity while adhering to established norms for reproducibility and openness.78 To enable result replication and bolster the general credibility of the research, researchers should enhance transparency by providing documentation of their software and analysis techniques.79
According to their study design and data type, statistical software tools direct researchers toward the most relevant statistical procedures, encouraging adherence to reporting requirements such as CONSORT and STROBE.80
Guideline updates emphasize increased clarity and transparency in presenting statistical methods, including software versions and specific analysis steps.81 They advocate for clearly reporting uncertainty measures and confidence intervals alongside P values, promoting a comprehensive understanding of research findings.82 There is also a growing emphasis on effective data visualization to enhance clarity and explicit reporting of potential limitations and sources of bias in statistical analysis.83

WRITING SOFTWARE AND ITS IMPACT ON RESEARCH REPORTING

Academic writers must have a fundamental understanding of how to use writing software. Several resources are accessible to help with different areas of writing thanks to the most recent sophisticated breakthroughs in this industry. These resources can benefit non-native English writers, especially regarding tasks like paraphrasing and improving grammar.84 How writing software is developing makes writing easier and makes academic writing much clearer and of higher quality overall. This is in line with the growing use of technology in academic research and communication. For non-Anglophone authors, LLMs such as ChatGPT provides a free solution that has historically prevented them from being on the same playing field as their native speakers. Because many professional language editing services have serious drawbacks, this is especially helpful for researchers from economically disadvantaged areas.85 The latest developments in writing software, particularly those driven by AI, might affect the students. While these technologies are practical and effective, there is reason to worry that the excessive reliance of the next generation on them may compromise their ability to think critically and write intricately.
Is ChatGPT a useful editing tool for people who don't speak English well? Lingard86 created a common method for using ChatGPT as a language editor and critically analyzing its output; they also offered numerous perspectives on applying LLMs as editing instruments. The study concluded that ChatGPT’s impressive text generation capacity is not matched by its editing capacity and advised the use of alternative AI tools, such as Quillbot, Grammarly, and ProWritingAid, which are intended exclusively for language editing and may provide more helpful grammar fixes.
Plagiarism in scholarly works is a serious issue of rising concern with the increased use of writing software. Plagiarism is against the core of academic integrity since it fails to credit the sources of one's ideas as well as the contributions of others.8788 Writers need to reproduce the meaning of the original ideas using their own words and sentence structure, ensuring a clear distinction between their contributions and those of others.8789 There are different terminologies used when it comes to plagiarism. Paraphragiarism occurs when a writer rephrases or paraphrases ideas from a source without giving proper credit or attribution to the original author.88 It may provide the false impression that the writer is the author of the ideas when taken from another source.88 There are many types of plagiarism which can be summarized as90:
  • 1. Plagiarism of ideas: A writer makes another person’s idea, thought, or invention appear as their own without proper acknowledgment; this can be hard to check but is considered a serious offense.

  • 2. Plagiarism of text (direct plagiarism): Copying sections of text from another source without providing citation or using quotation marks, a practice facilitated by technological advancements leading to increased instances of cut-copy-paste practices, is referred to as plagiarism. Plagiarism can occur even when copying small phrases without acknowledgment, and its detection relies on reviewers making careful comparisons.

  • 3. Mosaic plagiarism: When we borrow ideas and opinions from a source, along with using some exact words or phrases, without giving credit to the original author, it can lead to a presentation that feels tangled and mixed up. Properly referencing and citing sources helps to clarify which words are ours and which are borrowed from other writers. This type of plagiarism produces a “confused plagiarized mass” by hiding the differences between the concepts of the source and the original work. However, if we don't do this correctly, it can confuse our readers and raise ethical concerns.89

  • 4. Self-plagiarism: When we reuse large parts of our previous work without properly acknowledging it or citing it, people wonder if we're being transparent and following the rules of publication ethics. Asking permission to reuse our work and giving clear citations can help address these concerns. But suppose we end up with too much overlap or duplication in our articles; in that case, it wastes resources and raises ethical problems, harming the credibility of scholarly publications.

Detecting acts of using AI-driven writing software to generate content that is not original poses a complex problem. Although plagiarism detection tools are available, they might not be precise in identifying content produced by LLMs because of their continuous evolution.9192 Authors should acknowledge using AI tools or writing software, especially if they significantly contributed to the content.
It is suggested by the International Committee of Medical Journal Editors (ICMJE) that journals make it a requirement for authors to indicate whether they made use of AI-assisted tools such as LLMs or chatbots in generating their submitted articles, indicating how AI was utilized in the methods and acknowledgments section while emphasizing human responsibility for accuracy and integrity of AI content.9394 Moreover, all materials should be attributed correctly, authorship credit should not be given to AI, and there should be a declaration of AI-generated text and images on non-plagiarism.93 Failure to do so can be considered a breach of academic integrity and may undermine the credibility of research.
The question of whether employing ChatGPT in academic writing is plagiarism or not depends on how people interpret and view it. There has been a continuing debate within the academic community about using ChatGPT and other AI language models in research papers.95 According to the WAME, plagiarism refers to “…the use of others’ published and unpublished ideas or words (or other intellectual property) without attribution or permission, and presenting them as new and original rather than derived from an existing source.”96

CHALLENGES AND CONSIDERATIONS IN ADAPTING REPORTING STANDARDS IN THE ERA OF AI

Lund and Wang97 found that various ethical considerations in utilizing ChatGPT for academic writing have been identified, encompassing five key areas: bias concerns, privacy risks, autonomy and informed consent, transparency and accountability, and adherence to intellectual property regulations.97 Any language model might incorporate bias, typically resulting from the training process. Ray54 found 28 potential biases that users of ChatGPT may encounter. These biases include, among others:
  • 1. Availability bias: The propensity of ChatGPT to prefer data that is easier to remember or more accessible within its training set has been noted.

  • 2. Groupthink bias: By producing content that mirrors the consensus viewpoints or ideas revealed in its training data. This may reduce the range of views and make it more difficult to investigate opposing or divergent opinions.

  • 3. Commercial bias: Because ChatGPT’s training data primarily comes from the internet, it may represent the objectives and interests of commercial enterprises, which raises the possibility of commercial bias. This may cause the model to produce material that unintentionally promotes goods, services, or brands—even when the user does not mean it.

LLMs such as ChatGPT have notable limitations since they rely on training data and are unable to access current information from the internet, resulting in stagnant knowledge.98 Using ChatGPT to perform the same queries simultaneously produced different conversations, demonstrating the unpredictable nature of AI model behavior.99 The data are scattered, so it isn’t easy to work with or understand. Furthermore, these models cannot communicate with other systems, such as databases or APIs, which restrict their use in real-time applications that need to manipulate data.54 Furthermore, it’s unclear which particular data drives the model’s answers, making it difficult to grasp the basis of the outputs the lack of transparency is worrying.100 These restrictions make it difficult to guarantee accuracy, adaptability, and transparency when using LLMs.
The legal ramifications of ChatGPT are still being investigated.98 Legally speaking, since ChatGPT is not a person,101 who can be held accountable? In medicine, using electronic health record-based data research is a common practice. Patients’ sensitive medical information may be stored and made available to unknown parties by using this data and voluntarily entering it into AI analysis tools.102 Such data must be legally protected before attempting ChatGPT trials. When employing ChatGPT, security precautions such as encryption, access control, secure data storage, and adherence to privacy laws must be implemented to protect patient information.102
It is commonly recognized that LLMs can generate inaccurate and erroneous data.54100103 To ensure reproducibility, the use of LLMs to create content is expected in the current era, so tools that can detect AI-generated or human-generated texts could help ensure that a study is reproducible. However, sophisticated prompts and advanced AI technologies will likely evade these detection techniques. Instead of launching a pointless arms race between AI chatbots and AI chatbot detectors, publishers and the research community should collaborate to find ethical, open, and honest ways to use LLMs.56

Recommendations

Collaboration with specialists from numerous disciplines is essential for comprehending non-scientist viewpoints and foreseeing ethical, legal, and societal ramifications. Social sciences, law, and ethics are a few of these disciplines, but they are not the only ones. Organizations, publications, and the scholarly community must set forth precise rules and moral principles for the use of writing software.
Healthcare practitioners in non-English speaking countries might benefit from writing programmes and editing systems created at universities to help them write for and publish in peer-reviewed journals.104
The appropriate disclosure practices may be involved, original authorship and AI-assisted content generation may be distinguished, and researchers and students may be educated about the responsible use of these tools. The preservation of critical thinking abilities and ethical writing practices must be balanced with the advantages of efficiency to maintain the integrity of academic research and publications.
Park et al.105 created a double checklist of the PRISMA 2020 guidelines, which included descriptions of several often overlooked components as well as actual solutions for statistical analysis mistakes in published research. Using such checklists may increase reproducibility. Moreover, to address the challenges and considerations in adapting reporting standards in the era of AI, here are some concrete recommendations:
  • • Bias concerns:

    • 1. Use diverse data for training to cover various viewpoints.

    • 2. Regularly check for biases in models and involve different experts.

  • • Transparency and accountability:

    • 1. Follow standardized reporting like CONSORT-AI and METRICS.

    • 2. Be clear about model limitations and share details openly.

  • • Privacy and informed consent:

    • 1. Protect data with privacy methods like federated learning.

    • 2. Get clear consent from participants and follow data regulations.

  • • Standardizing healthcare AI reporting:

    • 1. Use tools like CLEAR and METRICS for consistent reporting.

    • 2. Work towards global standards and integrate them into reviews.

  • • Addressing language model limitations:

    • 1. Improve models with continuous learning and updates.

    • 2. Collaborate to find solutions for model limitations.

FUTURE DIRECTIONS

The EQUATOR Network offers a wide range of reporting standards, this makes it difficult for researchers to select and utilise the right ones, which is why EQUATOR is working to increase knowledge and motivation for correct usage.106 In October 2019, CONSORT and the EQUATOR expanded the CONSORT trial standards to incorporate trials aided by AI, or CONSORT-AI.107 The CONSORT-AI extension suggests expanding the current CONSORT 2010 statement with fourteen new checklist items (eleven extensions and three elaborations). In addition to the essential factors on the CONSORT 2010 checklist, these items were deemed significant enough to warrant routine reporting in clinical trial reports for AI therapies.108 This expansion is primarily meant for researchers and readers reporting on or evaluating clinical trials. However, it could also be helpful for those developing AI interventions when their systems are still in the early stages of validation.109
Sallam et al.110 developed a checklist that can be used to standardize reporting algorithms for AI-based studies in healthcare based on various methodologies and reports. This checklist can be used to standardize the Design and Reporting of Generative Artificial Intelligence-Based Studies in Healthcare Education and Practice. The checklist is known as “METRICS.” This may be the first beneficial step towards developing a well-recognized methodology to standardize reporting in AI-based healthcare research, a rapidly developing field of study. Additionally, they developed the “CLEAR” tool, a checklist intended to evaluate the caliber of health data provided by AI-based models. With the development of these approaches, a global agreement is required to establish reporting standards for every specific area of study.
The requirement for thorough reporting guidelines for clinical trials employing AI therapies is being addressed by the CONSORT-AI and Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT)-AI Steering Group.107 Despite the Food and Drug Administration having approved over thirty AI algorithms, the evidence supporting their efficacy in improving patient outcomes is largely limited to the diagnostic accuracy of these algorithms. The CONSORT and SPIRIT declarations, which disclose study protocols and randomized trials, have greatly improved transparency.111
We believe that the combination of powerful instruments can accelerate breakthroughs at a never-before-seen rate in a few life sciences disciplines, which is why we support their revolutionary potential. However, we also emphasize the importance of rigorous ethical scrutiny to ensure their use aligns with the greater good. To guide the world towards a responsible and balanced reliance on new technologies, journals, and associations should prioritize a full investigation of these ethical problems for the sake of humanity.
Scholarly publication, therefore, needs authors to evaluate and adhere to publication ethics, especially with the development of Open Access journals. These publications undermined evidence-based research by producing articles of such poor scientific quality. However, despite efforts to address the issue, such as adding unethical publications to the list of prohibited journals, posting the statements, and improving indexing criteria, no one solution is effective.112
It is important to note that the findings of this review may have some limitations. Our search was limited to English-written manuscripts, which could introduce language bias and exclude potentially important findings from non-English articles. Additionally, due to the large number of papers found, we were only able to search the PubMed and Scopus databases, potentially overlooking significant findings from other databases.

CONCLUSION

The creation of research reporting standards reflects measures to improve scientific transparency, rigor, and reproducibility. There are still concerns about plagiarism and ethical use even if ChatGPT and other AI applications have benefits for improving writing quality and translated text. The essential nature of collaboration, promptness, and adherence to publication ethics should be considered. Focused and trustworthy insights for research conclusions are ensured by statistical software. Transparency and replicability are enhanced by its collaboration with reporting standards, thus strengthening the basis for medical investigation. Future directions should encompass AI-aided trials as well as standardized reportage approaches. Global researchers must come to a consensus on actions to advance AI-based healthcare research. In short, new issues must be addressed, and technology must be used sensibly and openly by all parties. Together, we can manage challenging circumstances and ensure the public trusts our scientific research.

Notes

Disclosure: The authors have no potential conflicts of interest to disclose.

Data Availability Statement: Not applicable.

Author Contributions:

  • Conceptualization: Alnaimat F.

  • Investigation: Alnaimat F.

  • Supervision: Alnaimat F.

  • Writing - original draft: Al-Halaseh S, AlSamhori ARF.

  • Writing - review & editing: Alnaimat F, AlSamhori ARF.

References

1. Malički M, Aalbersberg IJ, Bouter L, Mulligan A, Ter Riet G. Transparency in conducting and reporting research: a survey of authors, reviewers, and editors across scholarly disciplines. PLoS One. 2023; 18(3):e0270054. PMID: 36888682.
2. Simera I, Moher D, Hirst A, Hoey J, Schulz KF, Altman DG. Transparent and accurate reporting increases reliability, utility, and impact of your research: reporting guidelines and the EQUATOR Network. BMC Med. 2010; 8(1):24. PMID: 20420659.
3. Turner L, Shamseer L, Altman DG, Weeks L, Peters J, Kober T, et al. Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals. Cochrane Database Syst Rev. 2012; 11(11):MR000030. PMID: 23152285.
4. Gawande A. The Checklist Manifesto: How to Get Things Right. 1st ed. New York, NY, USA: Metropolitan Books;2010.
5. Bergs J, Hellings J, Cleemput I, Zurel Ö, De Troyer V, Van Hiel M, et al. Systematic review and meta-analysis of the effect of the World Health Organization surgical safety checklist on postoperative complications. Br J Surg. 2014; 101(3):150–158. PMID: 24469615.
6. Haynes AB, Weiser TG, Berry WR, Lipsitz SR, Breizat AH, Dellinger EP, et al. A surgical safety checklist to reduce morbidity and mortality in a global population. N Engl J Med. 2009; 360(5):491–499. PMID: 19144931.
7. Gasparyan AY, Ayvazyan L, Blackmore H, Kitas GD. Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. Rheumatol Int. 2011; 31(11):1409–1417. PMID: 21800117.
8. Altman DG, Simera I. A history of the evolution of guidelines for reporting medical research: the long road to the EQUATOR Network. J R Soc Med. 2016; 109(2):67–77. PMID: 26880653.
9. Altman DG. The scandal of poor medical research. BMJ. 1994; 308(6924):283–284. PMID: 8124111.
10. Jüni P, Altman DG, Egger M. Systematic reviews in health care: assessing the quality of controlled clinical trials. BMJ. 2001; 323(7303):42–46. PMID: 11440947.
11. Simera I, Altman DG. Writing a research article that is “fit for purpose”: EQUATOR Network and reporting guidelines. Evid Based Med. 2009; 14(5):132–134. PMID: 19794009.
12. Grant A. Reporting controlled trials. Br J Obstet Gynaecol. 1989; 96(4):397–400. PMID: 2751952.
13. Squires BP, Elmslie TJ. Reports of randomized controlled trials: what editors want from authors and peer reviewers. CMAJ. 1990; 143(5):381–382. PMID: 2390750.
14. Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, et al. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA. 1996; 276(8):637–639. PMID: 8773637.
15. Simera I, Altman DG, Moher D, Schulz KF, Hoey J. Guidelines for reporting health research: the EQUATOR network’s survey of guideline authors. PLoS Med. 2008; 5(6):e139. PMID: 18578566.
16. Goodyear MD, Krleza-Jeric K, Lemmens T. The Declaration of Helsinki. BMJ. 2007; 335(7621):624–625. PMID: 17901471.
17. Tong A, Flemming K, McInnes E, Oliver S, Craig J. Enhancing transparency in reporting the synthesis of qualitative research: ENTREQ. BMC Med Res Methodol. 2012; 12(1):181. PMID: 23185978.
18. Husereau D, Drummond M, Petrou S, Carswell C, Moher D, Greenberg D, et al. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement. BMJ. 2013; 346(1):f1049. PMID: 23529982.
19. Wharton T. Rigor, transparency, and reporting social science research: why guidelines don’t have to kill your story. Res Soc Work Pract. 2017; 27(4):487–493. PMID: 28706432.
20. Munafò MR, Nosek BA, Bishop DVM, Button KS, Chambers CD, Percie du Sert N, et al. A manifesto for reproducible science. Nat Hum Behav. 2017; 1(1):0021. PMID: 33954258.
21. Patient-Centered Outcomes Research Institute (PCORI) Methodology Committee. Draft methodology report: “our questions, our decisions: standards for patient-centered outcomes research”. Updated 2012. Accessed March 30, 2024. https://www.pcori.org/assets/MethodologyReport-Comment.pdf .
22. Hutton B, Wolfe D, Moher D, Shamseer L. Reporting guidance considerations from a statistical perspective: overview of tools to enhance the rigour of reporting of randomised trials and systematic reviews. Evid Based Ment Health. 2017; 20(2):46–52. PMID: 28363989.
23. Jelinek T, Shumard A, Modi J, Smith C, Nees D, Hughes G, et al. Endorsement of reporting guidelines and clinical trial registration across Scopus-indexed rheumatology journals: a cross-sectional analysis. Rheumatol Int. 2024; 44(5):909–917. PMID: 37861727.
24. Christensen G, Wang Z, Levy Paluck E, Swanson N, Birke D, Miguel E, et al. Open science practices are on the rise: the state of social science (3S) survey. Updated 2020. Accessed March 30, 2024. https://escholarship.org/uc/item/0hx0207r .
25. Grant S, Wendt KE, Leadbeater BJ, Supplee LH, Mayo-Wilson E, Gardner F, et al. Transparent, open, and reproducible prevention science. Prev Sci. 2022; 23(5):701–722. PMID: 35175501.
26. Simera I, Moher D, Hoey J, Schulz KF, Altman DG. A catalogue of reporting guidelines for health research. Eur J Clin Invest. 2010; 40(1):35–53. PMID: 20055895.
27. Hariton E, Locascio JJ. Randomised controlled trials - the gold standard for effectiveness research: study design: randomised controlled trials. BJOG. 2018; 125(13):1716. PMID: 29916205.
28. Schulz KF, Altman DG, Moher D. CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMC Med. 2010; 8(1):18. PMID: 20334633.
29. Vandenbroucke JP, von Elm E, Altman DG, Gøtzsche PC, Mulrow CD, Pocock SJ, et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Epidemiology. 2007; 18(6):805–835. PMID: 18049195.
30. Sporbeck B, Jacobs A, Hartmann V, Nast A. Methodological standards in medical reporting. J Dtsch Dermatol Ges. 2013; 11(2):107–120. PMID: 23279950.
31. Panic N, Leoncini E, de Belvis G, Ricciardi W, Boccia S. Evaluation of the endorsement of the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) statement on the quality of published systematic review and meta-analyses. PLoS One. 2013; 8(12):e83138. PMID: 24386151.
32. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev. 2021; 10(1):89. PMID: 33781348.
33. Isaacs T, Chalmers H. Reducing ‘avoidable research waste’ in applied linguistics research: insights from healthcare research. Lang Teach. 2023; 1–18.
34. Gallo V, Egger M, McCormack V, Farmer PB, Ioannidis JP, Kirsch-Volders M, et al. STrengthening the Reporting of OBservational studies in Epidemiology--Molecular Epidemiology (STROBE-ME): an extension of the STROBE statement. PLoS Med. 2011; 8(10):e1001117. PMID: 22039356.
35. Gale NK, Heath G, Cameron E, Rashid S, Redwood S. Using the framework method for the analysis of qualitative data in multi-disciplinary health research. BMC Med Res Methodol. 2013; 13(1):117. PMID: 24047204.
36. Vlahov D. Transparent Reporting of Evaluations with Nonrandomized Designs (TREND). J Urban Health. 2004; 81(2):163–164. PMID: 15136648.
37. Shannon-Baker P. Making paradigms meaningful in mixed methods research. J Mixed Methods Res. 2016; 10(4):319–334.
38. Helm JM, Swiergosz AM, Haeberle HS, Karnuta JM, Schaffer JL, Krebs VE, et al. Machine learning and artificial intelligence: definitions, applications, and future directions. Curr Rev Musculoskelet Med. 2020; 13(1):69–76. PMID: 31983042.
39. Jarrahi MH. Artificial intelligence and the future of work: human-AI symbiosis in organizational decision making. Bus Horiz. 2018; 61(4):577–586.
40. Kaplan A, Haenlein M. Siri, Siri, in my hand: Who’s the fairest in the land? On the interpretations, illustrations, and implications of artificial intelligence. Bus Horiz. 2019; 62(1):15–25.
41. Tai MC. The impact of artificial intelligence on human society and bioethics. Tzu Chi Med J. 2020; 32(4):339–343. PMID: 33163378.
42. França C. AI empowering research: 10 ways how science can benefit from AI. arXiv. July. 17. 2023; DOI: 10.48550/arXiv.2307.10265.
43. AlSamhori AR, AlSamhori JF, AlSamhori AF. ChatGPT role in a medical survey. High Yield Med Rev. 2023; 1(2):
44. Masuadi E, Mohamud M, Almutairi M, Alsunaidi A, Alswayed AK, Aldhafeeri OF. Trends in the usage of statistical software and their associated study designs in health sciences research: a bibliometric analysis. Cureus. 2021; 13(1):e12639. PMID: 33585125.
45. Darsie JA. Statistical software properties: definition, inference and monitoring. Comput Sci Eng Theses Dissertations Stud Res. 2012. 48.
46. Godfrey AJR, Loots MT. Statistical software (R, SAS, SPSS, and Minitab) for blind students and practitioners. J Stat Softw. 2014; 58(1):1–25.
47. Muenchen RA. The popularity of data science software. Updated 2023. Accessed June 7, 2024. https://r4stats.com/articles/popularity/ .
48. Ell PS. A survey of visualisation tools in the social sciences. Updated 1999. Accessed March 30, 2024. http://www.agocg.ac.uk/reports/visual/survey/visurvey.pdf .
49. Everitt BS, Rabe-Hesketh S. Handbook of Statistical Analyses Using Stata. 4th ed. New York, NY, USA: Chapman and Hall/CRC eBooks;2006.
50. Tamkin A, Brundage M, Clark J, Ganguli D. Understanding the capabilities, limitations, and societal impact of large language models. arXiv. February. 4. 2021; DOI: 10.48550/arXiv.2102.02503.
51. Singhal K, Azizi S, Tu T, Mahdavi SS, Wei J, Chung HW, et al. Large language models encode clinical knowledge. Nature. 2023; 620(7972):172–180. PMID: 37438534.
52. Flanagin A, Bibbins-Domingo K, Berkwits M, Christiansen SL. Nonhuman “authors” and implications for the integrity of scientific publication and medical knowledge. JAMA. 2023; 329(8):637–639. PMID: 36719674.
53. Sallam M. ChatGPT utility in healthcare education, research, and practice: systematic review on the promising perspectives and valid concerns. Healthcare (Basel). 2023; 11(6):887. PMID: 36981544.
54. Ray PP. ChatGPT: a comprehensive review on background, applications, key challenges, bias, ethics, limitations and future scope. Internet Things Cyber Phys Syst. 2023; 3:121–154.
55. Al-Halaseh S, Alnaimat F. Enhancing reliability in anti-aging research: a call for adherence to reporting standards. Anti Aging East Eur. 2023; 2(4):189–192.
56. van Dis EA, Bollen J, Zuidema W, van Rooij R, Bockting CL. ChatGPT: five priorities for research. Nature. 2023; 614(7947):224–226. PMID: 36737653.
57. Ang TL, Choolani M, See KC, Poh KK. The rise of artificial intelligence: addressing the impact of large language models such as ChatGPT on scientific publications. Singapore Med J. 2023; 64(4):219–221. PMID: 37006087.
58. Schmidt PG, Meir AJ. Using generative AI for literature searches and scholarly writing: is the integrity of the scientific discourse in Jeopardy? Not Am Math Soc. 2024; 71(1):93–104.
59. Sample I. Science journals ban listing of ChatGPT as co-author on papers. Updated 2023. Accessed June 7, 2024. https://www.theguardian.com/science/2023/jan/26/science-journals-ban-listing-of-chatgpt-as-co-author-on-papers .
60. Venerito V, Gupta L. Large language models: rheumatologists’ newest colleagues? Nat Rev Rheumatol. 2024; 20(2):75–76. PMID: 38177451.
61. Yoo JH. Let’s look on the bright side of ChatGPT. J Korean Med Sci. 2023; 38(27):e231. PMID: 37431546.
62. Krusche M, Callhoff J, Knitza J, Ruffer N. Diagnostic accuracy of a large language model in rheumatology: comparison of physician and ChatGPT-4. Rheumatol Int. 2024; 44(2):303–306. PMID: 37742280.
63. Alnaimat F, Sweis NJ, Sweis JJ, Ascoli C, Korsten P, Rubinstein I, et al. Reproducibility and rigor in rheumatology research. Front Med (Lausanne). 2023; 9:1073551. PMID: 36687429.
64. Committee on Publication Ethics (COPE). Authorship and AI tools: COPE position statement. Updated 2023. Accessed June 7, 2024. https://publicationethics.org/cope-position-statements/ai-author .
65. Weidener L, Fischer M. Proposing a principle-based approach for teaching AI ethics in medical education. JMIR Med Educ. 2024; 10:e55368. PMID: 38285931.
66. Sprent P. Statistics in medical research. Swiss Med Wkly. 2003; 133(3940):522–529. PMID: 14655052.
67. Lottu OA, Ezeigweneme CA, Olorunsogo T, Adegbola A. Telecom data analytics: informed decision-making: a review across Africa and the USA. World J Adv Res Rev. 2024; 21(1):1272–1287.
68. Cooper H, Hedges LV, Valentine JC. The Handbook of Research Synthesis and Meta-Analysis. New York, NY, USA: Russell Sage Foundation;2019.
69. Greenhalgh T, Fahy N. Research impact in the community-based health sciences: an analysis of 162 case studies from the 2014 UK Research Excellence Framework. BMC Med. 2015; 13(1):232. PMID: 26391108.
70. Rehman A, Naz S, Razzak I. Leveraging big data analytics in healthcare enhancement: trends, challenges and opportunities. Multimedia Syst. 2022; 28(4):1339–1371.
71. Deaton A, Cartwright N. Understanding and misunderstanding randomized controlled trials. Soc Sci Med. 2018; 210:2–21. PMID: 29331519.
72. Batko K, Ślęzak A. The use of Big Data Analytics in healthcare. J Big Data. 2022; 9(1):3. PMID: 35013701.
73. Allioui H, Mourdi Y. Exploring the full potentials of IoT for better financial growth and stability: a comprehensive survey. Sensors (Basel). 2023; 23(19):8015. PMID: 37836845.
74. Wedel M, Kannan PK. Marketing analytics for data-rich environments. J Mark. 2016; 80(6):97–121.
75. Antwiadjei L. Evolution of business organizations: an analysis of robotic process automation. Eduzone Int Peer Rev Multidiscip J. 2021; 10(2):101–105.
76. Percie du Sert N, Ahluwalia A, Alam S, Avey MT, Baker M, Browne WJ, et al. Reporting animal research: explanation and elaboration for the ARRIVE guidelines 2.0. PLoS Biol. 2020; 18(7):e3000411. PMID: 32663221.
77. Alowais SA, Alghamdi SS, Alsuhebany N, Alqahtani T, Alshaya AI, Almohareb SN, et al. Revolutionizing healthcare: the role of artificial intelligence in clinical practice. BMC Med Educ. 2023; 23(1):689. PMID: 37740191.
78. Menke J, Eckmann P, Ozyurt IB, Roelandse M, Anderson N, Grethe J, et al. Establishing institutional scores with the rigor and transparency index: large-scale analysis of scientific reporting quality. J Med Internet Res. 2022; 24(6):e37324. PMID: 35759334.
79. O’Kane P, Smith A, Lerman MP. Building transparency and trustworthiness in inductive research through computer-aided qualitative data analysis software. Organ Res Methods. 2021; 24(1):104–139.
80. Miller JB, Schoenberg MR, Bilder RM. Consolidated Standards of Reporting Trials (CONSORT): considerations for neuropsychological research. Clin Neuropsychol. 2014; 28(4):575–599. PMID: 24766549.
81. Yuan I, Topjian AA, Kurth CD, Kirschen MP, Ward CG, Zhang B, et al. Guide to the statistical analysis plan. Paediatr Anaesth. 2019; 29(3):237–242. PMID: 30609103.
82. Colquhoun D. The reproducibility of research and the misinterpretation of p-values. R Soc Open Sci. 2017; 4(12):171085. PMID: 29308247.
83. Mohr DC, Schueller SM, Riley WT, Brown CH, Cuijpers P, Duan N, et al. Trials of intervention principles: evaluation methods for evolving behavioral intervention technologies. J Med Internet Res. 2015; 17(7):e166. PMID: 26155878.
84. Mondal H, Juhi A, Dhanvijay AD, Pinjar MJ, Mondal S. Free software applications for authors for writing a research paper. J Family Med Prim Care. 2023; 12(9):1802–1807. PMID: 38024912.
85. Doskaliuk B, Zimba O. Beyond the keyboard: academic writing in the era of ChatGPT. J Korean Med Sci. 2023; 38(26):e207. PMID: 37401498.
86. Lingard L. The writer’s craft. Perspect Med Educ. 2015; 4(2):79–80. PMID: 25850627.
87. Roig M. Avoiding Plagiarism, Self-Plagiarism, and Other Questionable Writing Practices: A Guide to Ethical Writing. Rockville, MD, USA: Office of Research Integrity;2011.
88. Levin JR, Marshall HH. Publishing in the Journal of Educational Psychology: reflections at midstream. J Educ Psychol. 1993; 85(1):3–6.
89. AMA Manual of Style Committee. AMA Manual of Style: A Guide for Authors and Editors. 11th ed. Oxford, UK: Oxford University Press;2020.
90. Das N, Panjabi M. Plagiarism: why is it such a big issue for medical writers? Perspect Clin Res. 2011; 2(2):67–71. PMID: 21731858.
91. Habibzadeh F. GPTZero performance in identifying artificial intelligence-generated medical texts: a preliminary study. J Korean Med Sci. 2023; 38(38):e319. PMID: 37750374.
92. Mitchell E, Lee Y, Khazatsky A, Manning CD, Finn C. DetectGPT: zero-shot machine-generated text detection using probability curvature. arXiv. July. 23. 2023; DOI: 10.48550/arXiv.2301.11305.
93. International Committee of Medical Journal Editors (ICMJE). Defining the role of authors and contributors. Updated 2024. Accessed June 7, 2024. https://www.icmje.org/recommendations/browse/roles-and-responsibilities/defining-the-role-of-authors-and-contributors.html .
94. Flanagin A, Pirracchio R, Khera R, Berkwits M, Hswen Y, Bibbins-Domingo K. Reporting use of AI in research and scholarly publication-JAMA Network guidance. JAMA. 2024; 331(13):1096–1098. PMID: 38451540.
95. Jarrah AM, Wardat Y, Fidalgo P. Using ChatGPT in academic writing is (not) a form of plagiarism: what does the literature say? Online J Commun Media Technol. 2023; 13(4):e202346.
96. World Association of Medical Editors (WAME). Recommendations on publication ethics policies for medical journals. Accessed June 7, 2024. https://wame.org/recommendations-on-publication-ethics-policies-for-medical-journals .
97. Lund BD, Wang T. Chatting about ChatGPT: how may AI and GPT impact academia and libraries? Libr Hi Tech News. 2023; 40(3):26–29.
98. Zhou J, Ke P, Qiu X, Huang M, Zhang J. ChatGPT: potential, prospects, and limitations. Front Inf Technol Electron Eng. 2024; 25(1):6–11.
99. Hosseini M, Horbach SP. Fighting reviewer fatigue or amplifying bias? Considerations and recommendations for use of ChatGPT and other large language models in scholarly peer review. Res Integr Peer Rev. 2023; 8(1):4. PMID: 37198671.
100. Fecher B, Hebing M, Laufer M, Pohle J, Sofsky F. Friend or foe? Exploring the implications of large language models on the science system. AI Soc. 2023.
101. Zhang J, Zhang ZM. Ethics and governance of trustworthy medical artificial intelligence. BMC Med Inform Decis Mak. 2023; 23(1):7. PMID: 36639799.
102. Wang C, Liu S, Yang H, Guo J, Wu Y, Liu J. Ethical considerations of using ChatGPT in health care. J Med Internet Res. 2023; 25:e48009. PMID: 37566454.
103. Meyer JG, Urbanowicz RJ, Martin PCN, O’Connor K, Li R, Peng PC, et al. ChatGPT and large language models in academia: opportunities and challenges. BioData Min. 2023; 16(1):20. PMID: 37443040.
104. Barroga E, Mitoma H. Improving scientific writing skills and publishing capacity by developing university-based editing system and writing programs. J Korean Med Sci. 2019; 34(1):e9. PMID: 30618516.
105. Park HY, Suh CH, Woo S, Kim PH, Kim KW. Quality reporting of systematic review and meta-analysis according to PRISMA 2020 guidelines: results from recently published papers in the Korean Journal of Radiology . Korean J Radiol. 2022; 23(3):355–369. PMID: 35213097.
106. Song JE. Strategies to improve the quality of reporting nursing research. Korean J Women Health Nurs. 2022; 28(2):77–82. PMID: 36312862.
107. CONSORT-AI and SPIRIT-AI Steering Group. Reporting guidelines for clinical trials evaluating artificial intelligence interventions are needed. Nat Med. 2019; 25(10):1467–1468. PMID: 31551578.
108. Liu X, Cruz Rivera S, Moher D, Calvert MJ, Denniston AK. SPIRIT-AI and CONSORT-AI Working Group. Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension. Nat Med. 2020; 26(9):1364–1374. PMID: 32908283.
109. Sallam M, Barakat M, Sallam M. A preliminary checklist (METRICS) to standardize the design and reporting of studies on generative artificial intelligence-based models in health care education and practice: development study involving a literature review. Interact J Med Res. 2024; 13:e54704. PMID: 38276872.
110. Sallam M, Barakat M, Sallam M. Pilot testing of a tool to standardize the assessment of the quality of health information generated by artificial intelligence-based models. Cureus. 2023; 15(11):e49373. PMID: 38024074.
111. Hopewell S, Boutron I, Chan AW, Collins GS, de Beyer JA, Hróbjartsson A, et al. An update to SPIRIT and CONSORT reporting guidelines to enhance transparency in randomized trials. Nat Med. 2022; 28(9):1740–1743. PMID: 36109642.
112. Gasparyan AY, Yessirkepov M, Voronov AA, Gorin SV, Koroleva AM, Kitas GD. Statement on publication ethics for editors and publishers. J Korean Med Sci. 2016; 31(9):1351–1354. PMID: 27510376.
TOOLS
Similar articles